ClinicalTrials.gg
CompletedNCT07794085Updated Aug 31, 2026

Growth and Nutritional Impact of Small Fish Powder Supplementation in Infants

An interventional study of Small Fish Powder and Millet Flour in Child Malnutrition, sponsored by Centre for Food and Nutrition Research, Yaounde. Completed at 1 site in Cameroon. Open to participants aged 6 Months to 7 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Centre for Food and Nutrition Research, Yaounde · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Jul 2024, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
6 Months to 7 Months
Sex
All
01

Study summary

This randomized controlled trial evaluated the effectiveness of supplementing the diets of infants aged 6-7 months with small fish powder on growth outcomes in the Garoua 1st Health District, Northern Cameroon. A total of 240 infants were enrolled and randomly assigned to receive either small fish powder or a millet flour control for six months. The primary endpoint was growth effectiveness, defined as achieving a height-for-age Z-score ≥ -1.5 after six months. Secondary outcomes included prevention of acute malnutrition, weight gain, mid-upper arm circumference (MUAC) gain, morbidity frequency, and intervention failure rate. Study procedures comprised weekly ration distribution, anthropometric measurements, hemoglobin and malaria testing, and parental nutritional education. Data were analyzed using SPSS and XLSTAT, with statistical significance set at p \< 0.05.

02

Conditions studied

  • Child Malnutrition

Keywords

  • Small fish powder
  • Complementary feeding
  • Infant malnutrition
  • Nutritional effectiveness
  • Northern Cameroon
03

In context

Child Nutrition Disorders

167 studies on the registry are indexed under Child Nutrition Disorders; 36 are open to participants now.

This study's enrollment of 240 is below the median of 402 across 132 interventional studies indexed under Child Nutrition Disorders.

Browse Child Nutrition Disorders studies →

Lead sponsor

Centre for Food and Nutrition Research, Yaounde is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 7 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants aged 6-7 months.
  • Families residing in the study area with no plans to relocate during the study period.
  • Absence of severe illness at enrollment.

Exclusion criteria

Exclusion Criteria:

  • Severe anemia.
  • Severe acute malnutrition.
  • Clinically defined illness such as dehydration, severe diarrhea, or respiratory disease.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
240 participants (actual)

Study arms

  • Experimental
    Small Fish Powder

    Dietary Supplement: Small Fish Powder · Dietary Supplement: Millet Flour

  • Active comparator
    Millet Flour

    Dietary Supplement: Small Fish Powder · Dietary Supplement: Millet Flour

Interventions

  • Dietary supplementSmall Fish Powder

    Infants aged 6-7 months will receive a daily ration of small fish powder equivalent to \~25 kcal/day, providing approximately 65% of the recommended daily protein intake for children aged 6-24 months. Parents will be instructed on how to incorporate the powder into the child's usual diet. Weekly distribution will occur at the health center, accompanied by monthly nutrition education and biweekly clinical monitoring.

  • Dietary supplementMillet Flour

    Infants aged 6-7 months will receive a daily ration of millet flour equivalent to \~25 kcal/day, providing approximately 10% of the recommended daily protein intake for children aged 6-24 months. To standardize taste, 3% fish powder will be added. Parents will be instructed on how to incorporate the flour into the child's usual diet. Weekly distribution will occur at the health center, accompanied by monthly nutrition education and biweekly clinical monitoring.

06

What researchers measure

Primary outcomes

  1. Height-for-Age Z-score

    Growth effectiveness, defined as the proportion of children achieving a height-for-age Z-score ≥ -1.5 SD after six months of supplementation.

    Time frame: 6 months

Secondary outcomes

  1. Weight-for-Height Z-score

    Prevention of acute malnutrition, defined as weight-for-height Z-score ≥ -1.5 SD.

    Time frame: 6 months

  2. Weight Gain

    Mean change in body weight (kg) from baseline to six months.

    Time frame: 6 months

  3. Mid-Upper Arm Circumference (MUAC) Gain

    Mean change in MUAC (cm) from baseline to six months.

    Time frame: 6 months

  4. Morbidity Frequency

    Number of morbidity episodes (e.g., diarrhea, respiratory infections, malaria) recorded per child during the six-month intervention period.

    Time frame: 6 months

  5. Intervention Failure Rate

    Proportion of children failing to achieve growth effectiveness (height-for-age Z-score \< -1.5 SD) after six months.

    Time frame: 6 months

Other outcomes

  1. Hemoglobin Concentration

    Mean change in hemoglobin levels (g/dL) from baseline to six months.

    Time frame: 6 months

  2. Malaria Prevalence

    Proportion of children testing positive for malaria by rapid diagnostic test (RDT) during follow-up.

    Time frame: 6 months

07

Study locations

1 site
  • Garoua 1 Health District
    Garoua, Cameroon
08

References and documents

Individual participant data

Plan to share: Yes — Baseline Characteristics: Infant age, sex, household sociodemographic data, maternal education, household food security and dietary diversity scores. Anthropometric Data: Weight, height/length, mid upper arm circumference (MUAC), Derived indices (height for age, weight for age, weight for height Z scores). Clinical and Laboratory Data: Hemoglobin concentration, Malaria test results, Morbidity episodes (diarrhea, respiratory infections, fever, malaria). Dietary Intake Data: 24 hour dietary recall, Weekly food frequency data, Product consumption records (amount of small fish powder or millet flour consumed, adherence, unused product returned). Follow up Data: Longitudinal measurements at enrollment, 2 months, 4 months, and 6 months, Survival analysis endpoints (growth recovery vs. non recovery).

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Feb 2025, 7 months.

Of 81 non-industry interventional studies with no phase under Child Nutrition Disorders, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 36. This study's 7 months is below that.

Counting every sponsor, half of 84 studies reached it within 19 months; a quarter within 11 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2026
First posted
Aug 31, 2026
StartActual
Jul 1, 2024
Primary completionActual
Feb 1, 2025
CompletionActual
Feb 1, 2025
Last update
Aug 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07794085
Lead sponsor
Centre for Food and Nutrition Research, Yaounde
Collaborators
Ministry of Public Health, Cameroon, UNICEF
Responsible party
Medoua Nama Gabriel (Principal Research Officer, Centre for Food and Nutrition Research, Yaounde) — Principal investigator
First posted
Aug 31, 2026
Start date
Jul 1, 2024
Primary completion
Feb 1, 2025
Completion
Feb 1, 2025
Last update
Aug 31, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion